Michael Felger said Tuesday on “Felger & Mazz” that he had heard a rumor the Red Sox could end up with Mike Trout, and he told listeners, “Don’t be surprised if we end up with Mike Trout.”
Felger did not present it as a hard report. “This is something that I can just kind of see happening — because it’s so out there,” he said, adding, “I can see it, but I’m not presenting this to you as, ‘baseball sources inform me that this is coming’.” He said, “I feel it’s my responsibility as a host of a one-source show,” and when Tony Massarotti responded, “Is loose,” Felger answered, “Very.”
The comment was enough to spark talk because Trout remains one of the most recognizable names in baseball. He is an 11-time All-Star, a three-time MVP and, for a stretch that lasted nearly a decade, the sport’s most dominant player. The Los Angeles outfielder is 34 years old and turns 35 in August, yet he is still producing in a bounce-back season. Through 41 games, Trout is batting.248 with 11 home runs, 23 RBI and a.924 OPS.
But any Red Sox pursuit would come with obvious baggage. Trout is making more than $37 million a year through the end of the 2030 season, and his recent health history is impossible to ignore. From 2020 to 2025, he appeared in 449 total games and played fewer than 55 games in three of those seasons. That is the part that would make a deal difficult for any team, even for a player with Trout’s track record.
Felger’s own description pointed to the same push and pull. He said, “He’s 100 years old, but they believe he is a better leader than [Alex] Bregman and will hit a bunch of home runs at Fenway Park and LA likes [Jarren] Duran and [Brayan] Bello.”
That is why the rumor matters beyond a radio bit. A Trout trade would require Boston to weigh an all-time talent against age, injuries and one of the largest contracts in the sport. For now, it remains exactly what Felger called it: something he can see happening because it is so far out there.
The next question is not whether Trout is still a star. It is whether any team would take on the risk that comes with paying star money to a player whose body has already made the last few seasons a partial schedule.
